Introduction - the problem:Treatment of oncological patients with targeted therapy has been carried out in our country for over 15 years. However, compared to some Western European countries and the USA, access to new drugs is limited and the reimbursement of genetic tests is not optimal. In order to...
Biznes i nauka razem.
Innowacje dla zdrowia i jakości życia.